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Abstract
Cyclic bis(30–50)diguanylic acid (cyclic-di-GMP) functions as a second messenger
in diverse species of bacteria to trigger wide-ranging physiological changes. We
measured cyclic-di-GMP and its structural analogs such as cyclic
bis(30–50)guanylic/adenylic acid (cyclic-GpAp), cyclic bis(30–50)guanylic/inosinic
acid (cyclic-GpIp) and monophosphorothioic acid of cyclic-di-GMP (cyclic-
GpGps) for effects on the bioﬁlm formation of Staphylococcus aureus and
Pseudomonas aeruginosa. We constructed a knockout mutant of SA0701, which is
a GGDEF motif protein relevant to diguanylate cyclase from S. aureus 2507. We
conﬁrmed that the bioﬁlm formation of this mutant (MS2507DSA0701) was
reduced. Cyclic-di-GMP corresponding to physiological intracellular levels given
in the culture recovered the bioﬁlm formation of MS2507DSA0701, whereas its
analogs did not, indicating that unlike a previous suggestion, cyclic-di-GMP was
involved in the positive regulation of the bioﬁlm formation of S. aureus and its
action was structurally speciﬁc. At a high concentration (200mM), cyclic-di-GMP
and its analogs showed suppression effects on the bioﬁlm formation of S. aureus
and P. aeruginosa, and according to the quantiﬁcation study using COSTATanalysis,
the suppression potential was in the order of cyclic-di-GMP, cyclic-GpGps, cyclic-
GpAp and cyclic-GpIp, suggesting that the suppression effect was not strictly
speciﬁc and the change of base structure quantitatively affected the suppression
activity.
Introduction
Cyclic bis(30–50)diguanylic acid (cyclic-di-GMP or c-di-
GMP) was discovered as an allosteric regulator of cellulose
biosynthesis in Gluconacetobacter xylinus (Acetobacter xyli-
num) (Ross et al., 1987). Recent research has accumulated
evidence indicating that cyclic-di-GMP is a novel second
messenger molecule of bacteria and regulates cell surface
events such as bioﬁlm formation and motility. Proteins
carrying the domains GGDEF and EAL or HD-GYP are
relevant to the activities of diguanylate cyclase and phos-
phodiesterase, respectively, and are involved in the metabo-
lism of cyclic-di-GMP (Tal et al., 1998; Ryan et al., 2006).
Proteins carrying the GGDEF domain are almost ubiquitous
in bacterial genomes except for only limited kinds of
bacteria (R¨ omling et al., 2005; Schmidt et al., 2005),
suggesting that cyclic-di-GMP is a universal messenger
molecule in bacteria. Intracellular cyclic-di-GMP promotes
bioﬁlm formation and suppresses motility at elevated levels
of concentration (Jenal & Malone, 2006; Kim & McCarter,
2007), whereas extracellular cyclic-di-GMP of high concen-
trations suppressed the bioﬁlm formation (Karaolis et al.,
2005).
Bacterial bioﬁlm on the surface of medical devices is a
major cause of hospital-associated infections (Lindsay &
von Holy, 2006; Wenzel, 2007). The control of the bioﬁlm
formation, therefore, is a prerequisite for the prevention of
bioﬁlm-associated infections. Compounds related in struc-
ture to cyclic-di-GMP are expected to have inhibitory
activities on bacterial bioﬁlm formation (Kline et al., 2008).
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SMoreover, the activities of these analogs will give us the
insight into the structural speciﬁcity of the target molecules
of cyclic-di-GMP. Cyclic-di-GMP can be bound by some
diguanylate cyclase enzymes to allosterically repress its own
synthesis (Chan et al., 2004; Wassmann et al., 2007). The
other known protein targets are G. xylinus cellulose synthase
and other PilZ domain proteins (Ross et al., 1985, 1987;
Ryjenkov et al., 2006), and Pseudomonas aeruginosa PelD
protein (Lee et al., 2007). It was found in a recent study that
cyclic-di-GMP in many bacterial species is sensed by a
riboswitch class in mRNA that controls the expression of
genes involved in numerous fundamental cellular processes
(Sudarsan et al., 2008). Although the control mechanisms by
cyclic-di-GMP for the development of Staphylococcus aureus
and P. aeruginosa bioﬁlms are not well understood and even
irrelevant in the bioﬁlm development of S. aureus as
suggested in a recent report (Holland et al., 2008), the
question whether riboswitches that sense cyclic-di-GMP are
involved in the regulatory pathway of cyclic-di-GMP re-
mains to be solved.
Hayakawa et al. (2003) developed a new method for the
chemical synthesis of cyclic-di-GMP in a high yield. In the
course of systematic investigation on the bioactivity of
cyclic-di-GMP-related compounds, they developed a syn-
thetic method for a cyclic-di-GMP derivative cyclic
bis(30–50)-20-deoxyguanylic/guanylic acid (cyclic-dGpGp)
and found that cyclic-dGpGp expressed a moderate sup-
pression effect on the bacterial bioﬁlm formation as well as
weak repression on the bacterial motility, as compared with
cyclic-di-GMP (Mano et al., 2007). They also synthesized
other analogs including analogs with modiﬁed nucleoside
bases or internucleotide bonds (Hyodo et al., 2006). The
present study was undertaken using cyclic-di-GMP and its
analogs to determine the structural speciﬁcity of recognition
of the targets that sense cyclic-di-GMP in the positive
regulation or negative regulation of the bacterial bioﬁlm
formation.
Materials and methods
Cyclic-di-GMP and its analogs
Cyclic-di-GMP and its analogs were chemically synthesized
as described previously (Hayakawa et al., 2003; Hyodo et al.,
2006). Cyclic-di-GMP analogs used in this study were cyclic
bis(30–50)guanylic/adenylic acid (cyclic-GpAp or c-GpAp),
cyclic bis(30–50)guanylic/inosinic acid (cyclic-GpIp or c-
GpIp) and monophosphorothioic acid of cyclic-di-GMP
(cyclic-GpGps or c-GpGps) (Hyodo et al., 2006). The
structures of these compounds are shown in Fig. 1. These
compounds were dissolved in 0.85% NaCl for use.
Bacterial strains and culture conditions
Pseudomonas aeruginosa strain PAO1 and S. aureus strain
MS2507 were used in this study. Staphylococcus aureus
MS2507 was isolated from the blood culture of a patient
and was a highly bioﬁlm-forming strain. These strains were
cultured in tryptic soy broth (TSB), Luria–Bertani (LB; 1%
Bacto tryptone, 0.5% Bactoyeast extract, pH 7.2% and 1.0%
NaCl) or on LB agar plates overnight at 371C before use.
Fig. 1. Structure of c-di-GMP and its analogs.
B in c-GpAp represents adenine, B in c-GpIp
represents inosine, and X in c-GpGps represents S.
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Based on the S. aureus N315 genome database, the sequence
of SA0701 (Bfd1, GdpS), which carries the GGDEF motif,
was identiﬁed (Tu Quoc et al., 2007; Holland et al., 2008). A
0.65-kb N-terminal fragment of the gene for SA0701 was
ampliﬁed with a forward primer TGCACTGCAGACCATT
TATTCACCTTCATC and a reverse primer GGGGTACCA
TAACAATCAACGTAACACC, and a 0.72-kb C-terminal
fragment was ampliﬁed with a forward primer ACGCGTC
GACAAGGGCGAAACAAAGTAATG and a reverse primer
ACGCGTCGACAAGGGCGAAACAAAGTAATG. The two
PCR products were digested with the relevant restriction
enzymes, and the N-terminal fragment was inserted into the
PstI–KpnI site and the C-terminal fragment was inserted
into the SalI–HindIII site of pYT3 (kindly provided by
Hiramatsu, Juntendo University, Tokyo). The resulting
plasmid pYT3DSA0701 was transformed into S. aureus
MS2507 as described previously (Schen & Laddaga, 1992).
The transformants were selected with the tetracycline resis-
tance phenotype at 421C to isolate a DSA0701 mutant
through a double-crossover recombination. The inactiva-
tion of the gene for SA0701 was veriﬁed using PCR, followed
by DNA sequencing (data not shown).
Quantification of biofilm formation
Quantiﬁcation of bioﬁlm formation by MS2507,
MS2507DSA0701 and PAO1 was performed using a crystal
violet staining method (Karaolis et al., 2005) with some
modiﬁcations. Bacteria were precultured on LB agar plates
at 371C overnight. Culture conditions for bioﬁlm formation
were LB for PAO1 and TSB for MS2507 and
MS2507DSA0701 at 301C 12-h static culture. The media
for bioﬁlm formation were supplemented with various
concentrations of synthetic cyclic-di-GMP and its analogs.
A single colony was inoculated into 4mL of LB or TSB and
incubated at 371C with constant shaking at 160r.p.m. until
late logarithmic stage. The culture was then diluted 1:10
4
with fresh LB or TSB supplemented with various concentra-
tions of cyclic-di-GMP and its analogs and a 200mL of the
diluted cultures was transferred into round-bottom wells of
a polystyrene microtiter plate (Iwaki, Tokyo, Japan). The
microtiter plate was incubated statically at 301C for 12h.
The supernatant was then discarded and the wells were
washed three times with 200mL of phosphate-buffered
saline. After the wells were dried, 200mL of 0.1% crystal
violet was added and the wells were stained at room
temperature for 15min. The wells were then washed three
times with distilled water to remove the extra dye and dried.
The dye staining the bioﬁlm in each well was extracted with
200mL of dimethyl sulfoxide and the OD570nm was mea-
sured with a plate reader (Tecan Austria GmbH, Austria).
These experiments were repeated at least three times, and
the results were expressed as the mean values SD. P-values
for signiﬁcance were calculated by the Student t-test.
Confocal laser scanning microscopic analysis of
biofilm and COMSTAT analysis of resultant images
PAO1 and MS2507 were prepared in the same way as those
described in the quantiﬁcation assay of the bioﬁlm. Freshly
prepared bacterial solutions were inoculated into 2mL of LB
for PAO1 and TSB for MS2507 supplemented with various
concentrations of cyclic-di-GMPor its analogs in glass-based
dishes (coverslip diameter 27mm, Iwaki) and were incubated
statically at 301C for 15h for PAO1 and 9h for MS2507. The
culture supernatant was discarded and the dishes were care-
fully rinsed three times with 0.85% NaCl and viability
staining of unﬁxed bioﬁlms was performed using BacLight
Live/Dead kit (L-7012, Molecular Probes) according to the
manufacturer’s recommendations to visualize bioﬁlms. The
bioﬁlms attached on the polyethyleneimine-coated glass
dishes (Iwaki) were observed at  400 magniﬁcation using a
confocal laser scanning microscope (LSM5 Pascal, Carl Zeiss
Co. Ltd). Images were acquired at a 1-mm interval through
the bioﬁlms and ﬁve image stacks, each representing a
different ﬁeld of view, and were compiled from at least two
independent experiments. The image stacks were analyzed
using the COMSTAT program (Heydorn et al., 2000) and the
following parameters were obtained: total biomass; mean
thickness, the mean height of the bioﬁlm; maximum thick-
ness; roughness coefﬁcient, a measure of how much the
thickness of the bioﬁlm varies; and surface-to-volume ratio,
anestimateoftheportionofthebioﬁlmexposedtonutrients.
Results
The activation effect of cyclic-di-GMP and its
analogs on S. aureus biofilm formation
A previous study showed that among a comprehensive
collection of bioﬁlm-defective mutants, a bfd1 (SA0701)-
knockout mutant was identiﬁed (Tu Quoc et al., 2007). The
gene bfd1 encodes a hypothetical protein that contains a
GGDEF motif. Holland et al. (2008), however, recently
suggested that Staphylococcus epidermidis and S. aureus
GdpS (same as SA0701) regulated staphylococcal bioﬁlm
formation independently of cyclic-di-GMP, although direct
evidences such as the measurements of intracellular cyclic-
di-GMP were not presented.
We also found in the staphylococcal whole-genome
database that SA0701 was the only suspected protein con-
taining a GGDEF motif relevant to the biosynthesis of
cyclic-di-GMP. We thus studied the effects of cyclic-di-
GMP and its analogs at low doses on the bioﬁlm formation
of a SA0701 (GdpS)-deﬁcient mutant to see whether these
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mation. We constructed an SA0701-deﬁcient mutant
MS2507DSA0701 from S. aureus MS2507, a bioﬁlm-positive
wild strain, using a gene-targeting method. In a preliminary
study, there was no difference in the growth rate in the
culture broth used for the bioﬁlm formation between
MS2507 and MS2507DSA0701 (data not shown), suggesting
that the inactivation of GdpS did not affect the growth of S.
aureus. As Fig. 2 shows, we found that MS2507DSA0701
formed a reduced level of bioﬁlm as compared with its
parent and that 0.02–0.2mM of cyclic-di-GMP enhanced the
bioﬁlm formation of MS2507DSA0701, although the level
of bioﬁlm was not fully recovered to that of the parent
(data not shown). We therefore suggest that cyclic-di-GMP
is involved in the regulation of the S. aureus bioﬁlm
formation, which is impaired by the loss of the function
of GdpS. Interestingly, higher concentrations (2–20mM)
of cyclic-di-GMP suppressed the bioﬁlm formation of
MS2507DSA0701. We also found that none of the cyclic-di-
GMP analogs showed positive regulatory effects on the
bioﬁlm formation of MS2507DSA0701.
Suppression effect of cyclic-di-GMP analogs at
high concentrations on biofilm formation
Both gram-negative P. aeruginosa PAO1 and gram-positive
S. aureus MS2507 form bioﬁlms on the surfaces of polystyr-
ene wells and polyethyleneimine-coated glass dishes. The
effects of three analogs, cyclic-GpAp, cyclic-GpIp and cyclic-
GpGps, on the formation of the bioﬁlm on the polystyrene
surface by these bacteria were measured. All of the three
analogs and cyclic-di-GMP suppressed the bioﬁlm forma-
tion of MS2507 at 200mM (Fig. 3). These compounds were
suppressive even at a low concentration (20mM), although
the effects were not high. Similar suppressive effects were
observed on the bioﬁlm formation of P. aeruginosa PAO1
when cyclic-GpGps, cyclic-GpAp and cyclic-di-GMP were
added at a concentration of 200mM (Fig. 3). On the other
hand, these compounds did not show a signiﬁcant suppres-
sive effect at 20mM. Cyclic-GpIp suppressed the bioﬁlm
formation of PAO1 at a low concentration but not at a high
concentration. Their suppressive effects at 200mM on the
bioﬁlm formation of both S. aureus and P. aeruginosa were
high in the order of cyclic-di-GMP, cyclic-GpGps, cyclicG-
pAp and cyclic-GpIp.
Similar results were obtained when these compounds
were measured for the effects on the bioﬁlm formation of
MS2507 and PAO1 with a confocal laser scanning micro-
scopy followed by the quantiﬁcation using the COMSTAT
program. Most of the bacterial cells within the bioﬁlms of
MS2507 and PAO1 in the presence of cyclic-di-GMP and its
analogs were alive as measured by qualitative viability
staining using the BacLight Live/Dead kit (data not shown).
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Fig. 2. Bioﬁlm formation of MS2507
and MS2507DSA0701, and effects of
cyclic-di-GMP and its analogs. (a) Bioﬁlm
formation at 301C 12h of MS2507 and
MS2507DSA0701 in TSB was measuredusing the
crystal violet staining method. The bioﬁlm
formation of MS2507DSA0701 was moderately
lower than that of the parent. (b) Bioﬁlm
formation of MS2507DSA0701 was measured by
the presence of cyclic-di-GMP and its analogs.
Only cyclic-di-GMP at low concentrations en-
hanced the bioﬁlm formation of
MS2507DSA0701. Po0.05; Po0.01.
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the killing of bacteria. This was also conﬁrmed with the
growth kinetics of MS2507 and PAO1 in a rich medium in
the presence of these compounds at 200mM (data not
shown). The COMSTAT analysis presented the scores of the
total biomass, average thickness, maximum thickness,
roughness and surface/volume ratio for the MS2507 bio-
ﬁlms in Table 1 and for the PAO1 bioﬁlms in Table 2.
Bioﬁlms of MS2507 and of PAO1 formed in the presence of
cyclic-di-GMP and cyclic-GpGps at 200mM had signiﬁ-
cantly lower total biomass, average thickness and maximum
thickness than those formed in the absence of the cyclic
nucleotide compounds. The suppressive effect of cyclic-
GpGps was almost similar to that of cyclic-di-GMP. On the
other hand, cyclic-GpAp showed only a moderate suppres-
sive effect and cyclic-GpIp did not show a clear suppressive
effect on the bioﬁlm formation of MS2507 and PAO1. The
scores of roughness and surface/volume for the MS2507
bioﬁlms and PAO1 bioﬁlms treated with cyclic-di-GMP and
cyclic-GpGps were much higher than those for the un-
treated bioﬁlms, suggesting that the bioﬁlms suppressed by
these compounds were rather rough and sparse.
Discussion
The present study exhibited that the target molecules of
cyclic-di-GMP that were involved in the bioﬁlm formation
recognized the difference of the base structure of cyclic
nucleotides as well as the monophosphorothioic acid struc-
ture. At low concentrations, cyclic-di-GMP enhanced S.
aureus bioﬁlm formation, which was reduced by the inacti-
vation of the GdpS gene, whereas none of the analogs
examined in this study showed such activity. The concentra-
tion of cyclic-di-GMP in the culture to show positive
regulation for the bioﬁlm formation ranged 0.02–0.2mM,
which was similar to the estimated intracellular concentra-
tion of cyclic-di-GMP in normal bacterial cells (Simm et al.,
2009). A previous report showed that the GGEEF (GGDEF)
motif of GdpS essential for diguanylate cyclase activity was



















































































































Fig. 3. Quantitative analysis of the suppressive
effect of cyclic-di-GMP and its analogs on
Staphylococcus aureus bioﬁlm formation (a) and
on Pseudomonas aeruginosa bioﬁlm formation
(b) using the crystal violet staining method. The
bioﬁlm of S. aureus MS2507 and P. aeruginosa
PAO1 was formed on wells of a polystyrene
microplate. The media for bioﬁlm formation were
supplemented with indicated concentrations of
synthetic cyclic-di-GMP and its analogs. After the
incubation, the bioﬁlm formed on the surface of
wells was stained with crystal violet. The dye
staining the bioﬁlm was then extracted and the
OD570nm was measured. Relative values of each
culture to the control culture containing none of
the synthetic cyclic-di-GMP and its analogs are
presented in the ﬁgure. Po0.05; Po0.01;
Po0.001.
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(Holland et al., 2008). On the other hand, we found that
cyclic-di-GMP functioned to recover the S. aureus bioﬁlm
formation, which was impaired by the inactivation of GdpS,
suggesting that cyclic-di-GMP can be involved in the
regulation of S. aureus bioﬁlm formation. Although, in a
recent study, the gdpS mutant displayed no difference in the
bioﬁlm formation capacity compared with the wild type
(Shang et al., 2009), the gdpS mutant constructed in this
study and a transposon-inserted mutant of gdpS isolated
from S. aureus S30 had an impaired bioﬁlm formation
capacity (Tu Quoc et al., 2007). It may possibly be due to
physiological differences among the strains, because strains
MS2507 and S30 exhibited a strong bioﬁlm-forming pheno-
type, whereas NCTC8325, which was used as the parent by
Shang, did not. It should be noted that in our preliminary
study the impaired bioﬁlm formation capacity of
MS2507DSA0701 was complemented by the introduction
of an intact gdpS gene on a plasmid. Because the activation
effect of extrinsic cyclic-di-GMP on the bioﬁlm formation
was observed in a GdpS-deﬁcient mutant, it is unlikely that
GdpS is the sole receptor of cyclic-di-GMP in the regulation
of S. aureus bioﬁlm formation. The presence of other targets
similar to previously reported proteins such as PilZ domain
proteins, PelD and FleQ, may also be possible although
bioinformatics analysis indicated the absence of such pro-
teins in S. aureus. Our results would provide a clue for
identiﬁcation of newcyclic-di-GMPsignaling pathways in S.
aureus bioﬁlm formation.
On the other hand, high doses of cyclic-di-GMP and the
analogs suppressed bioﬁlm formation of S. aureus and P.
aeruginosa, suggesting that the recognition speciﬁcity of the
relevant targets for the suppression of the bacterial bioﬁlm
formation was relatively lower than those for the positive
regulation. It should be noted again that the suppressive
concentrations of cyclic-di-GMP and its analogs added
in the culture were 100–1000 times higher than the esti-
mated physiological intracellular levels of cyclic-di-GMP
(Simm et al., 2009). Previous studies demonstrated that
intracellular cyclic-di-GMP produced by the overexpressed
biosynthesis genes promoted bioﬁlm formation in P. aeru-
ginosa (Kulasakara et al., 2006). In the report, intracellular
cyclic-di-GMP produced by overexpression of the biosynth-
esis genes was supposed to be a high level comparable to the
concentration of cyclic-di-GMP added in the culture, but
the bioﬁlm formation in overexpressed P. aeruginosa cells
was not suppressed. The concentration of intracellular
cyclic-di-GMP in overexpressed cells, however, was not
presented in these reports. The concentration of intracellu-
lar cyclic-di-GMP should be affected by the concentration of
GTP, the substrate of diguanylate cyclase and by phospho-
diesterase hydrolysis. We therefore speculate that the
Table 1. Quantitative analysis of MS2507 bioﬁlm formed in the presence of cyclic-di-GMP and its analogs.
Materials Biomass (mm
3mm
 2) Average thickness (mm) Maximum thickness (mm) Roughness coefﬁcient Surface/volume ratio
c-di-GMP 0.220 0.056 0.011 0.003 1.250 0.500 1.978 0.012 3.639 0.494
c-GpGps 0.229 0.001 0.015 0.012 1.250 0.500 1.970 0.024 3.605 0.469
c-GpAp 1.184 0.159 0.704 0.170 4.500 0.577 1.129 0.087 2.153 0.289
c-GpIp 1.614 0.289 1.008 0.308 4.000 0.000 0.750 0.093 1.714 0.116
No treatment 1.735 0.548 1.143 0.507 3.750 0.957 0.913 0.109 1.802 0.239




Table 2. Quantitative analysis of PAO1 bioﬁlm formed in the presence of cyclic-di-GMP and its analogs
Materials Biomass (mm
3mm
 2) Average thickness (mm) Maximum thickness (mm) Roughness coefﬁcient Surface/volume ratio
c-di-GMP 0.444 0.193 0.223 0.158 5.400 0.548 1.681 0.191 3.303 0.206
c-GpGps 0.453 0.125 0.273 0.131 4.600 1.140 1.677 0.095 3.549 0.240
c-GpAp 1.054 0.595 0.773 0.493 6.400 1.140 1.298 0.354 2.858 0.356
c-GpIp 2.618 0.451 2.343 0.570 11.167 2.483 0.638 0.091 2.105 0.125
No treatment 2.098 0.297 1.944 0.438 16.200 0.837 0.967 0.095 2.300 0.107
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pressed P. aeruginosa cells may be much lower than the
suppressive concentration of cyclic-di-GMP added in the
culture.
Because the suppression potential of cyclic-GpGps was
similar to that of cyclic-di-GMP whereas those of cyclic-
GpAp and cyclic-GpIp were much lower, the substitution of
the base structure rather than the replacement of oxygen
with sulfur in phosphate, which changes the electronic state
in the cyclic structure, would affect the suppression activity
of cyclic-di-GMP.
Cyclic-di-GMP can be bound bysome diguanylate cyclase
enzymes to allosterically repress its own synthesis (Chan
et al., 2004; Wassmann et al., 2007). The other known
protein targets are G. xylinus cellulose synthase (Ross et al.,
1985, 1987) and other PilZ domain proteins (Ryjenkov
et al., 2006), and P. aeruginosa PelD protein (Lee et al.,
2007). It was found in a recent study that cyclic-di-GMP, in
many bacterial species, is sensed by a riboswitch class in
mRNA that controls the expression of genes involved in
numerous fundamental cellular processes (Sudarsan et al.,
2008). Although the control mechanisms by cyclic-di-GMP
for the development of S. aureus and P. aeruginosa bioﬁlms
are not well understood, and previous studies suggested that
cyclic-di-GMP bound to its target proteins for the regula-
tion (Ross et al., 1985; Ryjenkov et al., 2006; Lee et al., 2007),
it is interesting to examine whether riboswitches are in-
volved in the cyclic-di-GMP signaling pathways for bioﬁlm
formation. Because the analogous cyclic nucleotides mea-
sured in this study expressed similar suppression activities
on the bioﬁlm formation and it seems that the differences
were not qualitative but quantitative, we speculate that these
compounds can function like cyclic-di-GMP.
In a previous study, Karaolis et al. (2005) demonstrated
that a high concentration of cyclic-di-GMP added extra-
cellularly suppressed the bioﬁlm formation of S. aureus.W e
found in the present study that low concentrations of cyclic-
di-GMP enhanced the S. aureus bioﬁlm formation and high
concentrations of extracellular cyclic-di-GMP suppressed
the formation of gram-negative P. aeruginosa bioﬁlm as well
as S. aureus bioﬁlm. Because cyclic-di-GMP is an intracel-
lular second messenger to regulate wide-ranging physiolo-
gical changes, it is rational to speculate that extracellular
cyclic-di-GMP penetrates through bacterial cells and ex-
presses its biological activities in the cells, although evi-
dences showing that cyclic-di-GMP penetrates across the
membrane have not yet been reported. If it is true, its
analogous compounds also likely penetrated through both
gram-positive and gram-negative bacterial cells in a similar
way, and suppressed bacterial bioﬁlm formation. However,
it is also possible that the regulation by extracellular cyclic-
di-GMP and its analogs is mediated by a cell surface
receptor.
Control of the bacterial bioﬁlm formation in vivo and in
vitro with synthetic compounds may be indispensable for
prevention of hospital-associated infections, because a large
number of such infections are associated with bacterial
bioﬁlms formed on the surface of artiﬁcial devices that are
introduced into patient bodies. The present study demon-
strated that the activities of cyclic-di-GMP and cyclic-
GpGps were higher than those of cyclic-GpAp and cyclic-
GpIp, suggesting a possibility for the development of
effective agents that interfere with the formation of bacterial
bioﬁlms.
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